These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28073423)

  • 21. Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells.
    Chen CY; Chi LM; Chi HC; Tsai MM; Tsai CY; Tseng YH; Lin YH; Chen WJ; Huang YH; Lin KH
    Mol Cell Proteomics; 2012 Apr; 11(4):M111.011270. PubMed ID: 22171322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21(Waf/Cip1) stabilization by activating the ERK1/2-MAPK pathway.
    Zhang Y; Liu Y; Duan J; Yan H; Zhang J; Zhang H; Fan Q; Luo F; Yan G; Qiao K; Liu J
    Hepatology; 2016 Mar; 63(3):880-97. PubMed ID: 26659654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A secretomic study on human hepatocellular carcinoma multiple drug-resistant cell lines.
    Xiang Y; Liu Y; Yang Y; Hu H; Hu P; Ren H; Zhang D
    Oncol Rep; 2015 Sep; 34(3):1249-60. PubMed ID: 26151126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. iTRAQ-coupled 2D LC-MS/MS analysis of secreted proteome of HBV-replicating HepG2 cells: potential in biomarkers for prognosis of HCC.
    Feng H; Wang M; Chen WN
    Curr Microbiol; 2010 Oct; 61(4):280-4. PubMed ID: 20165850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues.
    Gao Y; Wang X; Sang Z; Li Z; Liu F; Mao J; Yan D; Zhao Y; Wang H; Li P; Ying X; Zhang X; He K; Wang H
    Sci Rep; 2017 Apr; 7():45913. PubMed ID: 28378759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Stable isotope labeling and parallel reaction monitoring-based proteomic quantification for biomarker screening and validation of hepatocellular carcinoma].
    Wang S; Gao H; Zhang J; Ye X
    Se Pu; 2017 Sep; 35(9):934-940. PubMed ID: 29048850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isobaric Tag for Relative and Absolute Quantitation (iTRAQ)-Based Protein Profiling in Plants.
    Vélez-Bermúdez IC; Wen TN; Lan P; Schmidt W
    Methods Mol Biol; 2016; 1450():213-21. PubMed ID: 27424757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. iTRAQ-based proteomics reveals SOD2 as a potential salivary biomarker in liver cancer.
    Ding F; Sun K; Sun N; Jiang Q; Cao M; Wu Z
    Int J Biol Markers; 2019 Sep; 34(3):221-231. PubMed ID: 31041878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HST-MRM-MS: A Novel High-Sample-Throughput Multiple Reaction Monitoring Mass Spectrometric Method for Multiplex Absolute Quantitation of Hepatocellular Carcinoma Serum Biomarker.
    Jiang H; Zhang L; Zhang Y; Xie L; Wang Y; Lu H
    J Proteome Res; 2019 Jan; 18(1):469-477. PubMed ID: 30346787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.
    Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J
    Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The application of proteomics in different aspects of hepatocellular carcinoma research.
    Xing X; Liang D; Huang Y; Zeng Y; Han X; Liu X; Liu J
    J Proteomics; 2016 Aug; 145():70-80. PubMed ID: 27072111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Workflow of Mass Spectrometry-based Shotgun Proteomics of Tissue Samples.
    Verma A; Kumar V; Ghantasala S; Mukherjee S; Srivastava S
    J Vis Exp; 2021 Nov; (177):. PubMed ID: 34842228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo termini amino acid labeling for quantitative proteomics.
    Nie AY; Zhang L; Yan GQ; Yao J; Zhang Y; Lu HJ; Yang PY; He FC
    Anal Chem; 2011 Aug; 83(15):6026-33. PubMed ID: 21692469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver cancer-associated changes to the proteome: what deserves clinical focus?
    Mato JM; Elortza F; Lu SC; Brun V; Paradela A; Corrales FJ
    Expert Rev Proteomics; 2018 Sep; 15(9):749-756. PubMed ID: 30204005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection.
    von Felden J; Heim D; Schulze K; Krech T; Ewald F; Nashan B; Lohse AW; Wege H
    BMC Cancer; 2017 Jan; 17(1):60. PubMed ID: 28100188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors.
    Reis H; Pütter C; Megger DA; Bracht T; Weber F; Hoffmann AC; Bertram S; Wohlschläger J; Hagemann S; Eisenacher M; Scherag A; Schlaak JF; Canbay A; Meyer HE; Sitek B; Baba HA
    Biochim Biophys Acta; 2015 Jun; 1854(6):641-50. PubMed ID: 25448011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
    Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
    J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis of HBV-associated HCC: insights on mechanisms of disease onset and biomarker discovery.
    Niu D; Feng H; Chen WN
    J Proteomics; 2010 May; 73(7):1283-90. PubMed ID: 20188222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative proteomics of complex mixtures.
    Coombs KM
    Expert Rev Proteomics; 2011 Oct; 8(5):659-77. PubMed ID: 21999835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative Biomarkers to Predict Tumor Biology in Hepatocellular Carcinoma.
    Abreu P; Ferreira R; Mineli V; Ribeiro MA; Ferreira FG; DE Mello Vianna RM; Tomasich FDS; Szutan LA
    Anticancer Res; 2020 Dec; 40(12):6573-6784. PubMed ID: 33288552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.